Advanced Optics Electronics Inc. Debt-Free Status to Occur During 1st Q 2004; Biomoda Inc. Opens New HQ on Military Base.Business Editors ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Nov. 7, 2003 Advanced Optics Electronics Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:ADOT ADOT Arizona Department Of Transportation ADOT Alaska Department of Transportation ADOT Fédération des Associations pour le Don d'Organes et de Tissus Humains ADOT Active Duty Other Than Training ADOT Automatic Digital Optical Tracker ADOT Advanced Display Optimization Tools ), which previously confirmed the payment of all its bank debt, is preparing to eliminate the majority of all remaining debt by year end. The company has committed funds to achieve total debt-free status before the close of the first quarter of 2004. Delivery to Biomoda Inc. of the core laboratory assets of Phase-1 Molecular Toxicology (Santa Fe Santa Fe, city, Argentina Santa Fe, city (1991 pop. 341,000), capital of Santa Fe prov., NE Argentina, a river port near the Paraná, with which it is connected by canal. , N.M.) will commence Monday, 11-10-03, for installation at Biomoda's new research facility situated within the secure civilian research complex of a major operational military facility in New Mexico New Mexico, state in the SW United States. At its northwestern corner are the so-called Four Corners, where Colorado, New Mexico, Arizona, and Utah meet at right angles; New Mexico is also bordered by Oklahoma (NE), Texas (E, S), and Mexico (S). . Biomoda Inc.'s acquisition of this significant inventory as part of an all-cash transaction now enables the company's expanded team of Ph.D.s and scientists to accelerate the level of research to accelerate commercialization of a large portion of its proprietary technology for the early detection and treatment of lung cancer lung cancer, cancer that originates in the tissues of the lungs. Lung cancer is the leading cause of cancer death in the United States in both men and women. Like other cancers, lung cancer occurs after repeated insults to the genetic material of the cell. . Biomoda is nearly complete with the initial phase of its capital raising due to finish on or before 12-31-03. Biomoda projects initial listing on the NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on OTC Bulletin Board OTC Bulletin Board An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system. upon the completion of this phase of its initial capital raising. Advanced Optics Electronics Inc. is a technology company based in Albuquerque, N.M. The company maintains an R&D facility and manufacturing plant, and is engaged in building large-scale flat panel displays utilizing its patented and patent-pending technology. In addition to the core business of ADOT, the company has made a strategic technology-oriented investment in Biomoda Inc. Biomoda Inc. is a company that holds patents and patents pending domestically and internationally for the early detection of lung cancer. ADOT currently holds directly and indirectly 30 percent of Biomoda Inc. This news release contains forward-looking statements that involve a high degree of risk and uncertainty. Such statements include, but are not limited to, statements containing the words "believes," "anticipates," "expects," "estimates," and words of similar import. The company's actual results could differ materially from any forward-looking statements, which reflect management's opinions only as of the date of this report, as a result of risks and uncertainties that exist in our operation, development efforts and business environment. The company undertakes no obligation to revise or publicly release the results of any revisions to these forward-looking statements. You should carefully review the risk factors in other documents that the company files from time to time with the Securities and Exchange Commission, including its Quarterly Reports on Form 10-Q Form 10-Q See 10-Q. . |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion